William E. Kennard - 03 Jan 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anthony Lukaszewski, Authorized Signer
Issuer symbol
MET
Transactions as of
03 Jan 2023
Net transactions value
+$37,518
Form type
4
Filing time
05 Jan 2023, 15:28:47 UTC
Previous filing
16 Dec 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $37,518 +520 +1.5% $72.15 34,303 03 Jan 2023 Direct F1
holding MET Common Stock 10 03 Jan 2023 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of Common Stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.